PE20141553A1 - Compuestos de triazolopiridina como inhibidores de la ped10a - Google Patents

Compuestos de triazolopiridina como inhibidores de la ped10a

Info

Publication number
PE20141553A1
PE20141553A1 PE2014000366A PE2014000366A PE20141553A1 PE 20141553 A1 PE20141553 A1 PE 20141553A1 PE 2014000366 A PE2014000366 A PE 2014000366A PE 2014000366 A PE2014000366 A PE 2014000366A PE 20141553 A1 PE20141553 A1 PE 20141553A1
Authority
PE
Peru
Prior art keywords
compounds
heteroaryl
alkyl
aryl
ped10a
Prior art date
Application number
PE2014000366A
Other languages
English (en)
Inventor
Alexander Flohr
Zbinden Katrin Groebke
Matthias Koerner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46851999&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20141553(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20141553A1 publication Critical patent/PE20141553A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

SE REFIERE A COMPUESTOS DE FORMULA (I) EN DONDE: R1 ES ARILO, HETEROARILO O NR4R5, DICHOS ARILO Y HETEROARILO ESTAN OPCIONALMENTE SUSTITUIDOS POR 1 -3 SUSTITUYENTES SELECCIONADOS DE HIDROXILO, HALOGENO, ALQUILO, ENTRE OTROS; R4 Y R5 SON INDEPENDIENTEMENTE ALQUILO C1-C7, CICLOALQUILO C3-C8, JUNTO CON EL ATOMO DE N AL QUE ESTAN UNIDOS FORMAN UN HETEROCICLOALQUILO; R2 ES H, HALOGENO O ALQUILO C1-C7; R3 ES ARILO O HETEROARILO OPCIONALMENTE SUSTITUIDOS. SON COMPUESTOS PREFERIDOS: (2-DIETILAMINO-[1,2,4]TRIAZOLO[1,5-a]PIRIDIN-6-IL)-AMIDA DEL ACIDO 2-METIL-4-(AZETIDINA-4-CARBONIL)-2H-PIRAZOL-3-CARBOXILICO; (2-PIRROLIDIN-1-IL-[1,2,4])TRIAZOLO[1,5-a]PIRIDIN-6-IL)-AMIDA DEL ACIDO 2-METIL-4-(PIRROLIDINA-1-CARBONIL)-2H-PIRAZOL-3-CARBOXILICO; ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON UTILES PARA EL TRATAMIENTO DE TRASTORNOS PSICOTICOS, ESQUIZOFRENIA, ENFERMEDAD DE PARKINSON, ESCLEROSIS MULTIPLE
PE2014000366A 2011-09-19 2012-09-17 Compuestos de triazolopiridina como inhibidores de la ped10a PE20141553A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11181752 2011-09-19

Publications (1)

Publication Number Publication Date
PE20141553A1 true PE20141553A1 (es) 2014-10-30

Family

ID=46851999

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2014000366A PE20141553A1 (es) 2011-09-19 2012-09-17 Compuestos de triazolopiridina como inhibidores de la ped10a

Country Status (18)

Country Link
US (2) US8946427B2 (es)
EP (1) EP2758396B1 (es)
JP (1) JP2014526533A (es)
KR (1) KR101584925B1 (es)
CN (1) CN103827114B (es)
AU (1) AU2012311713A1 (es)
BR (1) BR112014006248A2 (es)
CA (1) CA2846758C (es)
CL (1) CL2014000641A1 (es)
CO (1) CO6900144A2 (es)
EA (1) EA201490599A1 (es)
ES (1) ES2626801T3 (es)
IL (1) IL231403A0 (es)
MX (1) MX2014003025A (es)
PE (1) PE20141553A1 (es)
SG (1) SG11201400759RA (es)
UA (1) UA108711C2 (es)
WO (1) WO2013041472A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013043518A1 (en) 2011-09-22 2013-03-28 Merck Sharp & Dohme Corp. Imidazopyridyl compounds as aldosterone synthase inhibitors
EP2757883B1 (en) * 2011-09-22 2021-01-13 Merck Sharp & Dohme Corp. Triazolopyridyl compounds as aldosterone synthase inhibitors
CA2909477A1 (en) * 2013-04-30 2014-11-06 F. Hoffmann-La Roche Ag Pd-catalyzed coupling of pyrazole amides
TWI652014B (zh) 2013-09-13 2019-03-01 美商艾佛艾姆希公司 雜環取代之雙環唑殺蟲劑
US9902723B2 (en) 2014-07-30 2018-02-27 Mochida Pharmaceutical Co., Ltd. Pyrazole derivative manufacturing method
WO2016017711A1 (ja) 2014-07-30 2016-02-04 持田製薬株式会社 ピラゾール誘導体の製造方法
WO2016144351A1 (en) 2015-03-11 2016-09-15 E. I. Du Pont De Nemours And Company Heterocycle-substituted bicyclic azole pesticides
WO2016144678A1 (en) 2015-03-12 2016-09-15 E I Du Pont De Nemours And Company Heterocycle-substituted bicyclic azole pesticides
WO2017062729A1 (en) 2015-10-08 2017-04-13 E. I. Du Pont De Nemours And Company Heterocycle-substituted bicyclic azole pesticides
JP7202360B2 (ja) * 2017-08-22 2023-01-11 バイエル・アクチエンゲゼルシヤフト 有害生物防除剤としてのヘテロサイクレン誘導体
EP3978077B1 (en) 2019-05-27 2023-11-29 Nihon Nohyaku Co., Ltd. Condensed heterocyclic compound having a bridgehead nitrogen atom or salt thereof, agricultural or horticultural insecticide comprising the compound, and method for using the insecticide
AR119140A1 (es) 2019-06-13 2021-11-24 Pi Industries Ltd Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas
CN110396157B (zh) * 2019-08-07 2021-07-30 广州市建筑科学研究院有限公司 缓释型聚羧酸纳米减水剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355653B1 (en) * 1999-09-06 2002-03-12 Hoffmann-La Roche Inc. Amino-triazolopyridine derivatives
CA2534432A1 (en) 2003-07-31 2005-02-10 Bayer Pharmaceuticals Corporation Methods for treating diabetes and related disorders using pde10a inhibitors
NL2000397C2 (nl) * 2006-01-05 2007-10-30 Pfizer Prod Inc Bicyclische heteroarylverbindingen als PDE10 inhibitoren.
WO2010035745A1 (ja) * 2008-09-25 2010-04-01 杏林製薬株式会社 ヘテロ環ビアリール誘導体及びそれらを有効成分とするｐｄｅ阻害剤
WO2010059836A1 (en) * 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
WO2010117926A1 (en) * 2009-04-07 2010-10-14 Schering Corporation Substituted triazolopyridines and analogs thereof
TWI402268B (zh) * 2009-09-24 2013-07-21 Hoffmann La Roche 新穎之咪唑并吡啶衍生物
EP3550853A1 (en) 2009-11-24 2019-10-09 Nokia Technologies Oy An apparatus
TW201200516A (en) * 2009-12-17 2012-01-01 Lundbeck & Co As H Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors
TWI487705B (zh) * 2009-12-17 2015-06-11 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基***衍生物
TWI485151B (zh) * 2009-12-17 2015-05-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物

Also Published As

Publication number Publication date
IL231403A0 (en) 2014-04-30
ES2626801T3 (es) 2017-07-26
EA201490599A1 (ru) 2014-07-30
NZ621597A (en) 2015-04-24
CN103827114A (zh) 2014-05-28
MX2014003025A (es) 2014-05-28
US20150099735A1 (en) 2015-04-09
WO2013041472A1 (en) 2013-03-28
CA2846758C (en) 2017-09-12
SG11201400759RA (en) 2014-07-30
CA2846758A1 (en) 2013-03-28
UA108711C2 (uk) 2015-05-25
EP2758396A1 (en) 2014-07-30
CN103827114B (zh) 2016-08-24
KR20140075716A (ko) 2014-06-19
AU2012311713A1 (en) 2014-03-13
EP2758396B1 (en) 2017-03-29
US20140303141A1 (en) 2014-10-09
KR101584925B1 (ko) 2016-01-12
CO6900144A2 (es) 2014-03-20
BR112014006248A2 (pt) 2017-04-11
CL2014000641A1 (es) 2014-11-14
US9227970B2 (en) 2016-01-05
JP2014526533A (ja) 2014-10-06
US8946427B2 (en) 2015-02-03

Similar Documents

Publication Publication Date Title
PE20141553A1 (es) Compuestos de triazolopiridina como inhibidores de la ped10a
CL2017001426A1 (es) Nuevos compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidin-2,7-diona 3-sustituidos para el tratamiento y profilaxis de infecciones virales.
UY33337A (es) DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS
CR20140397A (es) Compuestos de oxazolidin-2-ona y usos de los mismos como inhibidores de la pi3ks
GT201400301A (es) 7h-pirrolo [2,3-d] pirimidinas-4- ( aminho-substituidas) novedosas como inhibidores de lrrk2
EA201592146A1 (ru) Гетероароматические соединения и их применение в качестве лигандов к дофаминовым d1-рецепторам
UY34451A (es) Derivados de uracilo como inhibidores de la quinasa axl y c-met
PE20141205A1 (es) Spiro-[1,3]-oxacinas y spiro-[1,4]-oxacepinas como inhibidores de bace1 y/o bace2
EA201592082A1 (ru) 3,4-дигидроизохинолин-2(1h)-ильные соединения
PE20141540A1 (es) Derivados de 2-amino-4-(piridin-2-il)-5,6-dihidro-4h-1,3-oxazina y su uso como inhibidores de bace-1 y/o bace-2
PE20161066A1 (es) Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos
MX2014006026A (es) Derivados de aminopirimidina como moduladores de proteina cinasa 2 rica en unidades repetitivas de leucina (lrrk2).
ECSP13013038A (es) Inhibidores sustituidos de acetil-coa carboxilasa
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
ECSP13012611A (es) Derivados de pirazol-aminopirimidina como moduladores de la lrrk2
MX2016001011A (es) Derivados de quinazolin-4-ona sustituida.
PH12014501542B1 (en) Substituted pyrrolidine -2- carboxamides
AR072016A1 (es) Derivados de isoxazol que funcionan como potenciadores de los receptores de glutamato
NI201200061A (es) Derivados de quinazolina-4(3h)-ona utilizados como inhibidores de la cinasa de pi3
CO6470845A2 (es) Derivados de pirimidina novedosos y su uso en el tratamiento del cancer y enfermedades adicionales
NI201500134A (es) Derivados de 2-((4-amino-3-(3-flúor-5-hidroxifenil)-1h-pirazolo[3,4-d]pirimidin-1-il) metil)-3-(2-(trifluorometil)bencil)quinazolina-4(3h)-ona y su uso como inhibidores de fosfoinositida 3-quinasas
PE20142376A1 (es) Fluormetil-5,6-dihidro-4h-[1,3]oxazinas
PE20141578A1 (es) Derivados de [1,2,3]triazolo[4,5-d]pirimidina como agonistas del receptor de canabinoides 2
PE20141167A1 (es) Piridopirazinas sustituidas como inhibidores novedosos de ptk
GEP20166483B (en) Phenyl-3-aza-bicyclo[3.1.0] hex-3-yl-methanones and the use thereof as medicament

Legal Events

Date Code Title Description
FD Application declared void or lapsed